Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-002937

General Counsel sold 424 shares at $0.64 ($271)

From the SEC's structured data for this filing

Trades in this filing

Miller Edward · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-01-04 Sale : show line 1 in the form −424 $0.64 $271 235,534 D
Open-market sales · 424 sh · avg $0.64 · $271
Loading xslF345X05/ownership.xml…